Betamethasone Benzoate

Sold as Uticort. Every FDA application for this active ingredient.

As of Nov 15, 2026, FDA lists 4 applications for Betamethasone Benzoate (sold as Uticort), first approved Jun 28, 1974, with 0 new uses approved and 0 published complete response letters.

First approved: Jun 28, 1974
Applications: 4
New uses approved: 0
Complete response letters: 0

Clinical Trials

1 open or ongoing study names this ingredient as an intervention, including as a comparator; newest first. See all

Study	Phase	Status	Posted
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)Preterm Birth, Premature Birth · McMaster University	Phase 4	Recruiting	Nov 9, 2021

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history


Jun 28, 1974	UticortNDA 16998 · New dosage form	Parke Davis	3	Discontinued
—	UticortNDA 17244	Parke Davis	0	Discontinued
—	UticortNDA 17528	Parke Davis	0	Discontinued
—	UticortNDA 18089	Parke Davis	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA